Organizing pneumonia as a pulmonary manifestation of post-COVID syndrome: features of diagnosis and treatment
- 作者: Akulkina L.1, Shchepalina A.1, Kitbalian A.1,2, Potapov P.1,2, Moiseev A.1,2, Brovko M.1, Sholomova V.1, Moiseev S.1,2
-
隶属关系:
- Sechenov First Moscow State Medical University (Sechenov University)
- Lomonosov Moscow State University
- 期: 卷 94, 编号 4 (2022)
- 页面: 497-502
- 栏目: Original articles
- URL: https://journals.rcsi.science/0040-3660/article/view/108229
- DOI: https://doi.org/10.26442/00403660.2022.04.201452
- ID: 108229
如何引用文章
全文:
详细
Treatment of patients with long-term persistent symptoms after COVID-19 is an urgent problem for clinicians around the world. One of the most significant manifestations of post-COVID-19 syndrome is organizing pneumonia that is usually treat with corticosteroids. The paper presents a clinical case of typical course of post-COVID-19 organizing pneumonia in a patient without previous lung disease. Risk factors, diagnostic methods and treatment options in this group of patients are also discuss.
作者简介
Larisa Akulkina
Sechenov First Moscow State Medical University (Sechenov University)
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0002-4307-8882
ассистент каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.В. Склифосовского, врач-пульмонолог Клиники ревматологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы №3
俄罗斯联邦, MoscowAnastasia Shchepalina
Sechenov First Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0002-1826-0519
аспирант каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.В. Склифосовского
俄罗斯联邦, MoscowAram Kitbalian
Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0003-0546-988X
врач-пульмонолог Клиники ревматологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы №3, аспирант каф. внутренних болезней фак-та фундаментальной медицины
俄罗斯联邦, Moscow; MoscowPavel Potapov
Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0003-4366-2832
врач-пульмонолог Клиники ревматологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы №3, аспирант каф. внутренних болезней фак-та фундаментальной медицины
俄罗斯联邦, Moscow; MoscowAlexey Moiseev
Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0002-5296-7622
врач-пульмонолог отд-ния пульмонологии и профпатологии Клиники ревматологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы №3, аспирант каф. внутренних болезней фак-та фундаментальной медицины
俄罗斯联邦, Moscow; MoscowMikhail Brovko
Sechenov First Moscow State Medical University (Sechenov University)
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0003-0023-2701
канд. мед. наук, доц. каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины, зам. глав. врача по мед. части, врач-пульмонолог Университетской клинической больницы №3
俄罗斯联邦, MoscowVictoria Sholomova
Sechenov First Moscow State Medical University (Sechenov University)
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0002-8785-7968
канд. мед. наук, зав. отд-нием пульмонологии и профпатологии Клиники ревматологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы №3, ассистент каф. внутренних, профессиональных болезней и ревматологии Института клинической медицины им. Н.В. Склифосовского
俄罗斯联邦, MoscowSergey Moiseev
Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University
Email: anastasia.schepalina@yandex.ru
ORCID iD: 0000-0002-7232-4640
д-р мед. наук, проф. каф. внутренних профессиональных болезней и ревматологии Института клинической медицины, дир. Клиники ревматологии, внутренних и профессиональных болезней им. Е.М. Тареева Университетской клинической больницы №3, проф. каф. внут- ренних болезней фак-та фундаментальной медицины
俄罗斯联邦, Moscow; Moscow参考
- Wang MY, Zhao R, Gao LJ, et al. SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Front Cell Infect Microbiol. 2020;10:587269. doi: 10.3389/fcimb.2020.587269
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. doi: 10.1001/jama.2020.2648
- Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021;76(2):428-55. doi: 10.1111/all.14657
- Johns Hopkins University & Medicine, Coronovirus Resource Center. Available at: https://coronavirus.jhu.edu/. Accessed 10/21/2021.
- World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. 6 October 2021. Available at: WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021. Accessed 10/21/2021.
- Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv. 2021:2021.01.27.21250617. doi: 10.1101/2021.01.27.21250617
- Mo X, Jian W, Su Z, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55:2001217. doi: 10.1183/13993003.01217-2020
- Daher A, Balfanz P, Cornelissen C, et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med. 2020;174:106197. doi: 10.1016/j.rmed.2020.106197
- Zhao YM, Shang YM, Song WB, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463
- Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8
- Gulati A, Lakhani P. Interstitial lung abnormalities and pulmonary fibrosis in COVID-19 patients: a short-term follow-up case series. Clin Imaging. 2021;77:180-6. doi: 10.1016/j.clinimag.2021.03.030
- McGroder CF, Zhang D, Choudhury MA, et al. Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length. Thorax. 2021:thoraxjnl-2021-217031. doi: 10.1136/thoraxjnl-2021-217031
- Funk GC, Nell C, Pokieser W, et al. Organizing pneumonia following Covid19 pneumonia. Wien Klin Wochenschr. 2021;133(17-8):979-82. doi: 10.1007/s00508-021-01852-9
- Hwang DM, Chamberlain DW, Poutanen SM, et al. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol. 2005;18:1-10. doi: 10.1038/modpathol.3800247
- Yao HM, Zuo W, Wang XL, Zhang W. Findings on cryptogenic organizing pneumonia: a case report and literature review. J Int Med Res. 2020;48(4):300060520920068. doi: 10.1177/0300060520920068
- Zare Mehrjardi M, Kahkouee S, Pourabdollah M. Radio-pathological correlation of organizing pneumonia (OP): a pictorial review. Br J Radiol. 2017;90(1071):20160723. doi: 10.1259/bjr.20160723
- Cottin V, Cordier JF. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med. 2012;33(5):462-75. doi: 10.1055/s-0032-1325157
- Greenhalgh T, Knight M, A'Court C, et al. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. doi: 10.1136/bmj.m3026
- Golbets E, Kaplan A, Shafat T, et al. Secondary Organizing Pneumonia After Recovery of Mild COVID-19 Infection. J Med Virol. 2021;94(1):417-23. doi: 10.1002/jmv.27360
- Corvol H, Alimi A, Prevost B, et al. Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager. Clin Infect Dis. 2021;76(2):201-4. doi: 10.1136/thoraxjnl-2020-216088
- Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann Am Thorac Soc. 2021;18(5):799-806. doi: 10.1513/AnnalsATS.202008-1002OC
- Okamori S, Lee H, Kondo Y, et al. Coronavirus disease 2019-associated rapidly progressive organizing pneumonia with fibrotic feature: Two case reports. Medicine (Baltimore). 2020;99(35):e21804. doi: 10.1097/MD.0000000000021804
- Copin MC, Parmentier E, Duburcq T, et al. Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. Intensive Care Med. 2020;46(6):1124-6. doi: 10.1007/s00134-020-06057-8
- de Oliveira Filho CM, Vieceli T, de Fraga Bassotto C, et al. Organizing pneumonia: A late phase complication of COVID-19 responding dramatically to corticosteroids. Braz J Infect Dis. 2021;25(1):101541. doi: 10.1016/j.bjid.2021.101541
- Vadász I, Husain-Syed F, Dorfmüller P, et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76(2):201-204. doi: 10.1136/thoraxjnl-2020-216088
- Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J. 2006;27:143. doi: 10.1183/09031936.06.00114004
- Tachikawa R, Tomii K, Ueda H, et al. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic. Respiration. 2012;83:20. doi: 10.1159/000329893
- Park IN, Kim DS, Shim TS, et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest. 2007;132:214. doi: 10.1378/chest.07-0323
- Horita N, Akahane M, Okada Y, et al. Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2011;50:189. doi: 10.2169/internalmedicine.50.4327
- Inase N, Sawada M, Ohtani Y, et al. Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid. Intern Med. 2003;42:565. doi: 10.2169/internalmedicine.42.565
- Song JW, Hong SB, Lim CM, et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37:356. doi: 10.1183/09031936.00159709
- Miyazaki Y, Tateishi T, Akashi T, et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest. 2008;134:1265. doi: 10.1378/chest.08-0866
- Suda T, Kaida Y, Nakamura Y, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med. 2009;103:846. doi: 10.1016/j.rmed.2008.12.019
- Vadász I, Husain-Syed F, Dorfmüller P, et al. Severe organising pneumonia following COVID-19. Thorax. 2021;76(2):201-4. doi: 10.1136/thoraxjnl-2020-216088